MASLD is characterized by excessive hepatic fat accumulation in the absence of significant alcohol intake and is driven by multiple, interrelated mechanisms, including insulin resistance, mitochondrial dysfunction, oxidative stress, chronic inflammation, and genetic susceptibility [9,10]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.